Legalization

Trump smiling about the Bill Right To Try
Legalization

Trump To Sign Bill Which Could Make Cannabis Federally Legal For The Terminally Ill

The ‘Right To Try’ bill will legalize medications considered life-saving that have yet to go through the entire FDA-approval process.

May 24, 2018 - Miroslav Tomoski

US President Donald Trump speaks during a meeting with President Shavkat Mirziyoyev of Uzbekistan in the Oval Office of the White House in Washington, DC, May 16, 2018. (Photo by Saul Loeb/AFP/Getty Images)

Trump smiling about the Bill Right To Try

US President Donald Trump speaks during a meeting with President Shavkat Mirziyoyev of Uzbekistan in the Oval Office of the White House in Washington, DC, May 16, 2018. (Photo by Saul Loeb/AFP/Getty Images)

President Trump is set to sign legislation which could make medical marijuana federally legal for terminally ill patients. The bill, known as the “Right to Try Act,” would allow patients with potentially fatal conditions to try medications that have not yet been approved by the FDA, but are undergoing the approval process and have already passed the first phase of clinical studies.

Right to Try was passed unanimously by the Senate last summer and by the House of Representatives on Tuesday in a vote of 250 to 169.

While the bill’s provisions are targeted at a wide range of medications, it appears they might also apply to medical cannabis thanks to a clinical trial being conducted by the Multidisciplinary Association of Psychedelic Sciences (MAPS).

The MAPS trial, currently in the second phase of the FDA approval process, is testing the effectiveness of smoked cannabis in veterans with PTSD and meets all of the criteria set out by the Right to Try.

The majority of states already have their own form of Right to Try legislation, with one notable exception being New York. In Utah, a recently passed law specifically addresses the right of terminally ill patients to try cannabis. However, because cannabis remains federally prohibited, even if a terminally ill patient has the “Right to Try” cannabis on the state level, they’re still in violation of federal law. The Right to Try

Trump To Sign Bill Which Could Make Cannabis Federally Legal For The Terminally Ill1 Cannabis Cafes In Paris Are Trying To Claim The Bud They Sell Isnt For Smoking
A bottle of synthetic psilocybin is displayed for a photograph at the Bluestone Center for Clinical Research (BCCR) at the New York University (NYU) College of Dentistry in New York, U.S., on Wednesday, Nov. 30, 2011. New research in psychedelics such as psilocybin, the main ingredient in “magic mushrooms,” aims for therapeutic uses, such as treatments for anxiety, headaches or quitting smoking. (Photo by Paul Taggart/Bloomberg via Getty Images)

bill, recently passed by Congress, would change that. In addition to cannabis, MDMA and psilocybin could also potentially be used by ‘eligible patients’ since FDA trials of both substances meet the requirements set out in the federal bill.

What’s not clear is what illnesses qualify as life-threatening. Post-traumatic stress disorder, for example, could be argued to be life-threatening given the high rates of suicide among those who are diagnosed, but it’s up for debate. It’s likely that those details will be hammered out on a state by state basis in jurisdictions that have already passed their own version of Right to Try. The full title of the bill suggests as much stating, “in accordance with State law…”

However, in states that lack their own local provisions, the new bill appears to leave plenty of room for interpretation and a potential conflict with local drug laws.

Under the broad wording of the federal bill, no specific illnesses are mentioned. Instead, an ‘eligible patient’ is defined as, “Diseases or conditions where the likelihood of death is high unless the course of the disease is interrupted; and Diseases or conditions with potentially fatal outcomes, where the endpoint of clinical trial analysis is survival.”

Patients must also have exhausted all existing treatment options and must be unable to participate in the ongoing trials investigating the drug they want access to. Additionally, they must provide written consent from a qualified physician who does not stand to gain from the trial.

The bill passed on Tuesday after receiving some opposition from Democrats on Capitol Hill who believe that the law will undermine the FDA’s processes.

It’s likely that President Trump will sign the bill in the coming days since he has personally lobbied Congress for its passage. In January, Trump even mentioned the bill in his State of the Union Address saying, “People who are terminally ill should not have to go from country to country to seek a cure. I want to give them a chance right here at home. It is time for the Congress to give these wonderful, incredible Americans the right to try.”

Early Wednesday morning, Trump reiterated his support for the bill tweeting his intention to sign it into law.


Share This

Related Articles

Will the Federal Right to Try Act allow terminally ill patients to choose medical cannabis? Or will medical marijuana be left behind?

Does the new Right to Try law really allow terminally ill patients to access cannabis

As billionaires start to invest in psychedelics, some longtime researchers in the field worry they’ll just become another commodity.

Will Psychedelics Go Corporate Like Cannabis?

Rumors bubbled up last night that President Trump wants to let VA Secretary David Shulkin go. Will his replacement be more open to marijuana for veterans?

Will The VA’s Attitudes Toward Marijuana Change If Secretary Shulkin Gets Fired?

Comments

Stay in the loop

Exclusive deals, original content.
Delivered to you.